SUBSCRIBE
SUBSCRIBE
News   FDA

India’s Ranbaxy Laboratories’ Gets FDA Nod for Cyclobenzaprine HCL

May 15, 2008 | 
1 min read
MUMBAI, May 15 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration for muscle relaxant cyclobenzaprine hydrochloride tablets, the regulator's website showed.
FDA Approvals Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Regulatory
‘All Wrapper, No Gift’: FDA Releases New Rare Disease Approval Framework
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
Prasad Signals Steeper Requirements for COVID-19 Vaccines
September 3, 2025
 · 
3 min read
 · 
Tristan Manalac
FDA
Offit Out at FDA Vaccine Advisory Committee After HHS Rebuff
September 2, 2025
 · 
3 min read
 · 
Heather McKenzie
Brain neuro cell growth or damaging drawing with texture shading illustration isolated on dark background
Approvals
Biogen, Eisai Win FDA Nod for Subcutaneous Maintenance Leqembi
September 2, 2025
 · 
2 min read
 · 
Tristan Manalac